ECP 2026: Is HPV-Specific Testing Optimized in Throat Cancer?
Cost and turnaround times are a potential challenge to standardization of testing and optimization of patient pathways
09/14/2026
Video
2 min read

3 Topic Commentaries
ECP 2026: Is HPV-Specific Testing Optimized in Throat Cancer?
ECP 2026: Is HPV-Specific Testing Optimized in Throat Cancer?
Carole Fakhry, MD, MPH, MD, MPH
Otolaryngology–Head and Neck Surgery
•Johns Hopkins School of Medicine
Samip Patel, MD, MD
Otolaryngology–Head and Neck Surgery
•Mayo Clinic (Jacksonville, Florida)
Catherine Haring, MD, MD
Otolaryngology–Head and Neck Surgery
•University of Michigan
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.